Cipla enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,10,313————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
7,7938,6987,8825,4473,717
12788.395.895.9306
25825892.1247520
1,02,905————
−7,535−8,440−7,790−5,200−3,197
₹1,273.89————
35,78034,77831,38127,04924,234
0.7%0.7%0.3%0.9%2.1%
0.00×————
3.66×————
21.48×————
29.57×————
119.56×————
Reference items — trailing FY values
28,13928,16327,54825,77422,753
4,7905,8837,1286,2915,027
3,4804,6726,0215,2403,855
—3,9405,0054,1343,238
8618613,4572,7852,055
—8513,4492,7672,035
—3,0791,5481,3491,183
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CIPLA₹1,365.60

Cipla Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹1.10L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,10,313.2
- Cash, Equiv & ST Investments3,717.55,447.17,881.98,697.67,793.3
+ Minority Interest305.895.995.888.3126.7
+ Total Debt520.4247.092.1258.0258.0
Enterprise Value————1,02,904.5
Net Debt (memo)-3,197.1-5,200.1-7,789.8-8,439.7-7,535.3
EV per Share————1,273.89
Total Capital24,233.927,049.431,381.434,778.235,780.2
Total Debt/Total Capital2.150.910.290.740.72
Total Debt/EV————0.00
EV/Sales————3.66
EV/EBITDA————21.48
EV/EBIT————29.57
EV/Free Cash Flow————119.56
Reference Items — Trailing FY Values
Sales22,753.125,774.127,547.628,162.628,138.9
EBITDA5,027.06,291.17,127.95,882.94,790.1
EBIT3,854.95,240.06,021.04,671.93,479.7
Operating Cash Flow3,237.74,133.95,005.03,940.0—
Free Cash Flow2,054.82,784.63,456.8860.7860.7
FCFF (free cash flow to the firm)2,035.42,767.03,448.6851.1—
Capital Expenditure1,182.91,349.31,548.23,079.3—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.